HE4 is a Beneficial Biomarker in Endometrial Cancer
NCT03459976 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2019-01-25
Summary
Evaluation of Serum level of Human Epididymis Secretory Protein 4 (HE4) in Endometrial Cancer and clinical significant it
Conditions
Interventions
- DIAGNOSTIC_TEST
-
evaluate serum level HE4 in endometrial cancer
1. HE4 in beignin endometrial diseases 2. HE4 in endometrial cancer
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
M Elhafeez Assistant Professor Obstetrics and Gy, phD · Obstetrics and Gynecology
-
H Fathy Assistant Professor Obstetrics and Gy, phD · ASU
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2019-04-01
- Completion
- 2019-04-01
Countries
- Egypt
Study Locations
More Related Trials
-
An Observational Study Based on Endometrial Cancer Risk Screening Model
NCT05634798 ·Status: UNKNOWN
-
Endometrial Cancer International Database
NCT04787159 ·Status: UNKNOWN
-
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
NCT05273099 ·Status: UNKNOWN
-
Potential Value of Immunohistochemical Expression of SOX17 and E-Cadherin in Variable Endometrial Lesions
NCT06132230 ·Status: NOT_YET_RECRUITING
-
Methylated Biomarkers Predictive of Endometrial Cancer Risk
NCT06800677 ·Status: ACTIVE_NOT_RECRUITING
-
the Value of Immunohistochemical Expression of Moesin in Endometrial Hyperplasia and Endometrial Carcinoma
NCT05619159 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer
NCT05048173 ·Status: COMPLETED
-
Sentinel Lymph Node in Early-Stage Endometrium Cancer
NCT06163963 ·Status: RECRUITING ·Phase: NA
-
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
NCT03900104 ·Status: COMPLETED ·Phase: NA
-
Endometrial Cancer Screening in High-risk Populations
NCT06125886 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Biomarkers in Gynecological Cancers
NCT03420118 ·Status: RECRUITING ·Phase: NA
-
A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia
NCT06745427 ·Status: NOT_YET_RECRUITING
-
Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids
NCT02704650 ·Status: WITHDRAWN ·Phase: NA
-
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
NCT01793545 ·Status: COMPLETED
-
Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)
NCT06632431 ·Status: RECRUITING
-
Adipocytokines in Endometrial Cancer
NCT05018195 ·Status: UNKNOWN ·Phase: NA
-
GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
NCT07279571 ·Status: NOT_YET_RECRUITING
-
Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue
NCT07040657 ·Status: RECRUITING ·Phase: NA
-
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer
NCT04302714 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Diagnosis of Endometrial Cancer
NCT05737797 ·Status: RECRUITING ·Phase: NA
-
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
NCT05646316 ·Status: RECRUITING ·Phase: PHASE3
-
Survival and Reproductive Outcomes of Malignant Ovarian Germ Cell Tumors
NCT05905289 ·Status: COMPLETED
-
A Cohort Study of Uterine Malignancies
NCT05635123 ·Status: RECRUITING
-
The Effect of Androgen Receptor Polymorphism on Endometrial Cancer
NCT05157373 ·Status: UNKNOWN
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING